Mitsui will promote sales of FDCA and PEF for Dutch Avantium in Asia

As Avantium is preparing to build its first production plant of 2,5-furan dicarboxylic acid (FDCA), it has rreached agreement with Mitsui & Co. that the latter will be a major promotor for this substitute of PET in Japan and beyond. Mitsui sees good chances to...

MEXT revises the roadmap of iPS cell research

Following expert discussions, clinical application for each type of cell (clinical studies or trials) are now scheduled as follows (in parentheses the schedules announced in February 2013). 2016 or 2017: dopamine-producing nerve cells (2016-2018) 2018: neural stem...